73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
How does obesity cause cancer?

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee
Early disease detection in body fluids using photonic biosensors

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and

Early disease detection in body fluids using photonic biosensors

by Anne-Julie Zichner, Fraunhofer-Institut für Photonische Mikrosysteme (IPMS)Photonic biosensor chip of Fraunhofer IPMS Credit: Fraunhofer IPMSStandard medical procedures are often time-consuming and
MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell
First test of anti-cancer agent PAC-1 in human clinical trials shows promise

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B
Study shows early success of a novel drug in treating a rare and chronic blood cancer

Study shows early success of a novel drug in treating a rare and chronic blood cancer

by The Mount Sinai HospitalCredit: Pixabay/CC0 Public DomainA novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red bl

Study shows early success of a novel drug in treating a rare and chronic blood cancer

by The Mount Sinai HospitalCredit: Pixabay/CC0 Public DomainA novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red bl
Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in
Team learns how to predict triple negative breast cancer recurrence

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and
Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio

Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio
The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer